Federally Qualified Health Centers (FQHCs) are outpatient health centers that provide comprehensive primary care to 30 million low-income individuals.1 When the coronavirus disease 2019 (COVID-19) pandemic began in March 2020, the Centers for Medicare & Medicaid Services (CMS) granted flexibilities to FQHCs to furnish video and telephone (audio only) visits to patients at any location. Pandemic-related regulatory waivers led to a substantial increase in telehealth across the health care system.2
Little is known about visit trends during the COVID-19 pandemic among patients of FQHCs. We described trends in the use of in-person, telephone, and video visits among California FQHCs before and during the COVID-19 pandemic.
In July 2020, the California Health Care Foundation (CHCF) provided funding to expand telehealth capacity for 43 health centers (including 20% of California’s FQHCs) and provide data for evaluation through a reporting tool aligned with the Health Resources and Services Administration Uniform Data System (UDS).3 The FQHCs submitted aggregated data on billable outpatient primary care and behavioral health visits, reporting in-person, telephone, and video visits for each month by patient demographics from February 2019 to August 2020.
Using UDS data on characteristics of FQHCs,3 we analyzed descriptive statistics comparing FQHCs participating in the CHCF initiative and FQHCs not participating. We calculated the number of primary care and behavioral health visits (by visit type) per 1000 patients served in 2019. We estimated fixed-effects linear regressions examining changes in the log-transformed number of primary care and behavioral health visits during the March-August 2020 pandemic period relative to February 2019–February 2020, controlling for time-invariant differences of FQHCs and monthly seasonality. Statistical significance was defined as a 2-sided P < .05. The analyses were conducted using Stata version 16.1 (StataCorp). The RAND Corporation institutional review board declared the study exempt.
Forty-one FQHCs with 534 physical locations provided data. The FQHCs participating in the CHCF initiative served 1.7 million patients in 2019 and were similar to FQHCs in California that were not included in the sample; however, the smallest FQHCs (serving ≤9999 patients in 2019) were underrepresented (Table).
During the prepandemic period, there was a mean of 231.7 primary care visits per 1000 patients per month compared with 228.6 visits per 1000 patients per month during the COVID-19 pandemic period. Adjusted models showed a 6.5% decrease (95% CI, −104% to −2.3%; P = .03) in total visit volume for primary care, with the decline concentrated in March and April 2020. There was no significant change in total behavioral health visits (Figure).
Prior to the COVID-19 pandemic, there was minimal telehealth use. During March 2020, FQHCs rapidly substituted in-person visits with telephone and video visits. During the pandemic period, there were 109.9 in-person, 111.0 telephone, and 7.8 video visits per 1000 patients per month for primary care, with 48.1% occurring in person, 48.5% via telephone, and 3.4% via video. For behavioral health, there were 6.6 in-person, 18.2 telephone, and 4.0 video visits per 1000 patients per month, with 22.8% occurring in person, 63.3% via telephone, and 13.9% via video. Telephone visits peaked in April 2020, comprising 65.4% of primary care visits and 71.6% of behavioral health visits.
During the COVID-19 pandemic, visit volume at a sample of FQHCs declined modestly for primary care visits and remained stable for behavioral health visits because telehealth visits (particularly by telephone) replaced in-person visits. Few studies have differentiated between telehealth modalities. However, CMS estimated that 30% of telehealth visits were audio only during the pandemic.2 Estimates reported here may be higher because low-income patients face unique barriers to accessing video visits and FQHCs lack resources to develop the necessary infrastructure. Study limitations include that only FQHCs in 1 state were tracked. Also, 5 FQHCs reported early challenges distinguishing visit types and categorized all telehealth visits by the dominant modality.
Prior to the pandemic, many definitions of telehealth excluded telephone visits, and telephone visits were seldom reimbursed.4,5 Furthermore, CMS signaled it may stop reimbursing for telephone visits when the public health emergency ends.6 There are some concerns that telephone visits could result in fraud, abuse, and unnecessary and lower-quality care. Although these concerns are important to assess, eliminating coverage for telephone visits could disproportionately affect underserved populations and threaten the ability of FQHCs to meet patient needs.
Corresponding Author: Lori Uscher-Pines, PhD, MSc, RAND Corporation, 1200 S Hayes St, Arlington, VA 22202 (luscherp@rand.org).
Accepted for Publication: January 11, 2021.
Published Online: February 2, 2021. doi:10.1001/jama.2021.0282
Author Contributions: Dr Uscher-Pines had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Uscher-Pines, Sousa, Jones, Whaley, Perrone, Ober.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Uscher-Pines, Sousa, Whaley, Ober.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Whaley, McCullough, Ober.
Obtained funding: Uscher-Pines, Ober.
Administrative, technical, or material support: Sousa, Jones, Perrone.
Supervision: Uscher-Pines, McCullough.
Conflict of Interest Disclosures: Dr Whaley reported receiving grants from the National Institute on Aging. Mr Perrone reported receiving personal fees from and being employed by the California Health Care Foundation. No other disclosures were reported.
Funding/Support: This work was supported by grant G-31038 from the California Health Care Foundation.
Role of the Funder/Sponsor: The California Health Care Foundation was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript; but was not involved in the decision to submit the manuscript for publication.